Member eligibility renewals are happening. Members - find out what to do to keep your insurance.
PROVIDERS AFFECTED: All providers
Updated information on Hennepin Health’s current support of telehealth services and COVID-19 specific codes being used during the pandemic. This bulletin supplies summary information on how Hennepin Health has implemented CMS and DHS updates.
Effective April 1, 2020, Hennepin Health began covering medically necessary services and consultation by providers through telephonic telemedicine in the same manner as if the service or consultation was delivered in person on an interim basis during the coronavirus (COVID-19) pandemic (Minnesota Statutes, 254B.05, subdivision 5(f) and 256B.0625, subdivision 3b).
Effective April 1, 2020, Hennepin Health included delivery of services through telephone connection between the patient and provider as part of telemedicine services. Telephone services will be allowed for the duration of the coronavirus (COVID-19) pandemic.
Hennepin Health requires providers to have submitted Provider Assurance statement for delivery of telehealth services. We utilize the DHS provider enrollment file to verify appropriate assurance statements are in place on the date services are provided.
Providers should complete one of the following forms located on the DHS provider enrollment website and submit to provider enrollment. If you have completed form DHS-6806, you do not need to complete an additional DHS – 6806A form.
We recommend that providers bill place of service 02 for services provided via telehealth. CPT code should represent time spent with members.
Providers are to bill Modifier 95 should only be appended to the appropriate CPT or HCPCS code when providing synchronous telemedicine service rendered via a real-time interactive audio and video telecommunications system.
Per Families First Coronavirus Response Act, Hennepin Health has waived copays for services related to COVID-19 including testing, diagnostic and treatment services. There are no in-network restrictions for testing, diagnostic or treatment services.
Providers are advised bill modifier CS for specified COVID-19 testing related services that result in an order for or administration of a COVID-19 test. Lab and diagnostic services are not subject to cost sharing and this will assist in identifying physician services associated with COVID-19 lab testing billed on separate claims. Physician services billed in conjunction with lab services are not required to bill CS modifier.
All Hennepin Health members do not require authorization to access out-of-network providers for diagnostic testing and outpatient treatment associated with COVID-19.
Hennepin Health systems have been updated to accept the following codes.
COVID-19 lab codes
CDC-2019 Novel Coronavirus Real Time RT-PCR Diagnostic Test Panel
2019-nCoV Coronavirus, SARS-CoV-2/2019-nCoV (COVID-19),
Infectious agent detection by nucleic acid (DNA or RNA); severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-19]), amplified prove technique, making use of high throughput technologies as described by CMS-2020-01-R
2019nCoV Coronavirus, SARS-CoV-2/2019-nCoV (COVID-19), any technique, multiple types or subtypes (includes all targets), non-CDC, making use of high throughput technologies
Specimen collection for severe acute respiratory syndrome Coronavirus2 (SARS-CoV-2) (Coronavirus disease [COVID-19]), from an individual in a skilled nursing facility or by a laboratory on behalf of a home health agency, any specimen source
Specimen collection for severe acute respiratory syndrome Coronavirus2 (SARS-CoV2) (Coronavirus disease [COVID-19]), any specimen source
Severe acute respiratory syndrome Coronavirus2 (SARS-CoV2) (Coronavirus disease [COVI-19])
Immunoassay for Infectious Agent Antibody(ies), Qualitative or semi-quantitative Single Step Method (e.g., Reagent Strip); Sever Acute Respiratory Syndrome Coronavirus2 (SARS-CoV1) (Coronavirus disease [COVID-19])
Antibody; Severe Acute Respiratory Syndrome Coronavirus2 (SARS-CoV2) (Coronavirus disease [COVID-19])
Microbiological laboratory testing for severe acute respiratory syndrome Coronavirus2 (SARS-CoV-2)
Hospital outpatient clinic visit specimen collection for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
Diagnosis code description
Providers may bill the following: